Both in Pharmaceuticals
Oruka Therapeutics vs Kiniksa Pharmaceuticals International
Over the past year ORKA returned +269.7% and KNSA returned +149.4%; their daily moves had a correlation of 0.16.
ORKA +269.7% KNSA +149.4%Growth of $1, one year, split-adjusted
| Metric | ORKA | KNSA |
|---|---|---|
| Price | $101.41 | $96.12 |
| Market cap | $6.71B | $7.55B |
| Today | +1.87% | +3.03% |
| 1 month | +26.5% | +24.7% |
| 6 months | +45.3% | +65.1% |
| Year to date | +234.6% | +133.0% |
| 1 year | +287.2% | +156.5% |
| Revenue growth (YoY) | — | +58.1% |
| Gross margin | — | 90.3% |
| Net margin | — | 16.6% |
| P/E (TTM) | — | 68.9× |
| Price / sales | — | 8.0× |
| Net cash | $873.6M | $462.9M |
| Dividend yield | — | — |
| Volatility (60d) | 51.8% | 54.2% |
| Short % of float | 11.5% | 9.6% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).